144 related articles for article (PubMed ID: 14713270)
1. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma.
Botella-Carretero JI; Galán JM; Caballero C; Sancho J; Escobar-Morreale HF
Endocr Relat Cancer; 2003 Dec; 10(4):601-10. PubMed ID: 14713270
[TBL] [Abstract][Full Text] [Related]
2. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
Botella-Carretero JI; Gómez-Bueno M; Barrios V; Caballero C; García-Robles R; Sancho J; Escobar-Morreale HF
Endocr Relat Cancer; 2004 Jun; 11(2):345-56. PubMed ID: 15163309
[TBL] [Abstract][Full Text] [Related]
3. Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal.
Gao YC; Gu Q; Liu QP; Ge WL; Lu HK
Clin Lab; 2010; 56(3-4):87-93. PubMed ID: 20476639
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
Ain KB; Pucino F; Shiver TM; Banks SM
Thyroid; 1993; 3(2):81-5. PubMed ID: 8369656
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone deficiency and postmenopausal status independently increase serum osteoprotegerin concentrations in women.
Botella-Carretero JI; Alvarez-Blasco F; San Millán JL; Escobar-Morreale HF
Eur J Endocrinol; 2007 May; 156(5):539-45. PubMed ID: 17468189
[TBL] [Abstract][Full Text] [Related]
7. Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
Vigário Pdos S; Chachamovitz DS; Teixeira Pde F; Rocque Mde L; Santos ML; Vaisman M
Arq Bras Endocrinol Metabol; 2014 Apr; 58(3):274-81. PubMed ID: 24863090
[TBL] [Abstract][Full Text] [Related]
8. The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal.
Botella-Carretero JI; Prados A; Manzano L; Montero MT; Escribano L; Sancho J; Escobar-Morreale HF
Eur J Endocrinol; 2005 Aug; 153(2):223-30. PubMed ID: 16061828
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life, Anxiety and Depression in Patients with Differentiated Thyroid Cancer under Short Term Hypothyroidism Induced by Levothyroxine Withdrawal.
Badihian S; Jalalpour P; Mirdamadi M; Moslehi M
Klin Onkol; 2016; 29(6):439-444. PubMed ID: 27951721
[TBL] [Abstract][Full Text] [Related]
10. Preparation for radioactive iodine administration in differentiated thyroid cancer patients.
Liel Y
Clin Endocrinol (Oxf); 2002 Oct; 57(4):523-7. PubMed ID: 12354135
[TBL] [Abstract][Full Text] [Related]
11. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer.
Burmeister LA; Goumaz MO; Mariash CN; Oppenheimer JH
J Clin Endocrinol Metab; 1992 Aug; 75(2):344-50. PubMed ID: 1639933
[TBL] [Abstract][Full Text] [Related]
12. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
14. Effects of Levothyroxine Administration and Withdrawal on the Hypothalamic-Pituitary-Thyroid Axis in Euthyroid Dogs.
Ziglioli V; Panciera DL; Troy GC; Monroe WE; Boes KM; Refsal KR
J Vet Intern Med; 2017 May; 31(3):705-710. PubMed ID: 28432797
[TBL] [Abstract][Full Text] [Related]
15. Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal.
Botella-Carretero JI; Alvarez-Blasco F; Sancho J; Escobar-Morreale HF
Thyroid; 2006 Apr; 16(4):397-402. PubMed ID: 16646687
[TBL] [Abstract][Full Text] [Related]
16. Free thyroid hormones and a third-generation TSH assay in the detection of hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients.
Taimela E; Koskinen P; Nuutila P; Nikkanen V; Saraste M; Taimela S; Irjala K
Scand J Clin Lab Invest; 1995 Apr; 55(2):181-6. PubMed ID: 7667611
[TBL] [Abstract][Full Text] [Related]
17. Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
Papadakis G; Kalaitzidou S; Triantafillou E; Drosou A; Kakava K; Dogkas N; Pappa T; Kaltzidou V; Tertipi A; Villiotou V; Pappas A
Anticancer Res; 2015 Dec; 35(12):6933-40. PubMed ID: 26637919
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdrawal for whole body scanning.
Chow SM; Au KH; Choy TS; Lee SH; Yeung NY; Leung A; Leung A; Leung HL; Shek CC; Law SC
Laryngoscope; 2006 Nov; 116(11):2060-6. PubMed ID: 17075410
[TBL] [Abstract][Full Text] [Related]
19. The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma.
Moon JH; Ahn S; Seo J; Han JW; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Kim KW; Jang HC
J Clin Endocrinol Metab; 2014 Oct; 99(10):3782-9. PubMed ID: 25029415
[TBL] [Abstract][Full Text] [Related]
20. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
